UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in IRMD — Iradimed Corp

CIK 861177 NEW YORK, NY

Back to IRMD Full portfolio

Position in IRMD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,455,931

+$8,892 QoQ

Shares Held

15,125

+1.7% QoQ

Ownership

0.118%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 28% Shared 0% None 72%

Common Shares in IRMD Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $6,140,526,672 across 63 Medical Devices names. IRMD ranks #39 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	13,198,740	$1,355,114,632
2	BSX	Boston Scientific Corp	13,513,771	$847,989,125
3	MDT	Medtronic plc	9,733,748	$843,429,259
4	SYK	Stryker Corp	2,208,201	$725,592,760
5	DXCM	Dexcom Inc	9,746,174	$612,059,721
6	EW	Edwards Lifesciences Corp	5,458,148	$437,088,487
7	STE	STERIS plc	1,253,502	$277,186,892
8	GEHC	GE HealthCare Technologies Inc.	2,521,213	$179,459,935

All Filings in IRMD

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,455,931	15,125	+1.7%	Shares	Defined	2026-05-13
2025-12-31	$1,447,039	14,875	+21.1%	Shares	Defined	2026-02-13
2025-09-30	$873,844	12,280	-52.9%	Shares	Sole	2025-11-14
2025-06-30	$1,559,083	26,076	+37.5%	Shares	Defined	2025-08-14
2025-03-31	$995,440	18,968	+3.3%	Shares	Defined	2025-05-19
2024-12-31	$1,009,745	18,359	+91.5%	Shares	Defined	2025-02-14
2024-09-30	$482,029	9,585	-20.3%	Shares	Defined	2024-11-14
2024-06-30	$528,641	12,031	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.